Compliance
★    

India,
2012-07-11 08:39
(5101 d 02:00 ago)

Posting: # 8923
Views: 3,268
 

 Dose increment [Design Issues]

Dear All,

Kindly let me know under what circumstances we can increases the dose volume? My drug is measured with the less amount of doses (5 ml) under fasting condition but during fed, few of the subject concentration comes BLQ. Due to this we have decided to increases the dose twice.

Is the dose increases due to this reason is acceptable? I don’t feel (might be not correct) this is a sensitivity issue related to bioanalytical. I feel this is a issue related to formulation. Kindly correct my understanding.

Awaiting for your reply for my better understanding.

Regards,

Compliance
hiren379
★    

India,
2012-07-11 13:23
(5100 d 21:16 ago)

@ Compliance
Posting: # 8926
Views: 2,567
 

 Dose increment

❝ Kindly let me know under what circumstances we can increases the dose volume? My drug is measured with the less amount of doses (5 ml)


First of all my good friend, dose when given in mL always comes with the concentration of the dosage form. But concidering that same concentration is used for both fast and fed read my below responce.

❝ under fasting condition but during fed, few of the subject concentration comes BLQ.


Why only few...Is the drug highly variable?

❝ Due to this we have decided to increases the dose twice.


I think you need to check the following

1) If the drug is not reaching saturation kinetics by increasing the dose
2) Ethics committe agrees to high dose
3) You have enough justification why yr LLOQ is low.
4) No recomendations given by OGD (If you are talking for USFDA)

If yr concern is that regulatory will shout at you, then stay cool if above criteria are met.
UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
239 visitors (0 registered, 239 guests [including 16 identified bots]).
Forum time: 10:40 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5